Efficacy and safety of ocrelizumab in patients with relapsing multiple sclerosis: Real-world experience of two Swiss multiple sclerosis centers

Autor: Diem, L, Ovchinnikov, A, Friedli, C, Hammer, H, Kamber, N, Chan, A, Salmen, A, Findling, O, Hoepner, R
Zdroj: In Multiple Sclerosis and Related Disorders June 2024 86
Databáze: ScienceDirect